Advancing Innovation and Access to Vaccines

BioNet commits to develop and manufacture innovative high-quality vaccines that comply with applicable regulatory requirements. BioNet aims to integrate quality beyond compliance in both products and processes through continuous improvement of our quality system. Our vaccines are manufactured in accordance to Good Manufacturing Practices (GMP) PIC/S standards, and tested at each manufacturing step as per pharmacopeia requirements in our own quality control and testing facilities.

Recombinant Pertussis Vaccines

The world’s only manufacturer of licensed recombinant pertussis vaccines.
BioNet is manufacturing recombinant monovalent pertussis vaccine (Pertagen®), recombinant TdaP vaccine (Boostagen®) and recombinant Tdap vaccine (BoostagenRED®) containing genetically-inactivated pertussis toxin (PTgen).